IDEXX Laboratories, Inc. (IDXX)Healthcare | Diagnostics & Research | Westbrook, United States | NasdaqGS
554.99 USD
+9.91
(1.818%)
⇧
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 554.99 |
Hot Take ↕ | Aug. 22, 2026, 3:36 a.m. EDT
IDEXX is a fundamentally elite compounder with a seventy-four percent return on equity and robust free cash flow, yet it trades at a premium valuation with no dividend yield to cushion the cost of ownership. While the long-term trajectory is undeniable with nearly five hundred percent gains over nine years, the stock is currently lagging its longer-term moving averages and carries a high-confidence negative forecast for the next forty-five days. Options traders are betting on a recovery toward the six-hundred-dollar mark, but the technical setup suggests a period of consolidation or further weakness before the next leg up. For investors seeking capital appreciation, the business quality is unmatched, but the timing is less favorable than the fundamentals alone would suggest. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.020852 |
| MSTL | 0.021791 |
| AutoETS | 0.023245 |
| AutoTheta | 0.025341 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 71% |
| H-stat | 1.04 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.678 |
| Excess Kurtosis | -0.16 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 67.971 |
| Revenue per Share | 57.169 |
| Market Cap | 43,779,276,800 |
| Trailing P/E | 38.30 |
| Forward P/E | 33.15 |
| Beta | 1.54 |
| Profit Margins | 25.03% |
| Website | https://www.idexx.com |
As of Aug. 22, 2026, 3:36 a.m. EDT: Speculators are positioning for upside with heavy call open interest at strikes between 600 and 740, indicating a bullish bias for the medium term. However, put activity remains concentrated near the money (520-550) with notable volume spikes in deep out-of-the-money strikes (340-350), suggesting a hedge against a sharp decline or speculative tail-risk bets. Implied volatility is elevated across expirations, reflecting uncertainty around the upcoming earnings event.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.14757997 |
| Address1 | One IDEXX Drive |
| All Time High | 769.98 |
| All Time Low | 0.84375 |
| Ask | 553.17 |
| Ask Size | 1 |
| Audit Risk | 5 |
| Average Analyst Rating | 2.2 - Buy |
| Average Daily Volume10 Day | 485,440 |
| Average Daily Volume3 Month | 629,917 |
| Average Volume | 629,917 |
| Average Volume10Days | 485,440 |
| Beta | 1.542 |
| Bid | 554.21 |
| Bid Size | 2 |
| Board Risk | 6 |
| Book Value | 20.445 |
| City | Westbrook |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 5 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 554.99 |
| Current Ratio | 1.172 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 556.01 |
| Day Low | 545.48 |
| Debt To Equity | 67.971 |
| Display Name | IDEXX Laboratories |
| Earnings Call Timestamp End | 1,785,846,600 |
| Earnings Call Timestamp Start | 1,785,846,600 |
| Earnings Growth | 0.176 |
| Earnings Quarterly Growth | 0.151 |
| Earnings Timestamp | 1,785,846,600 |
| Earnings Timestamp End | 1,793,622,600 |
| Earnings Timestamp Start | 1,793,622,600 |
| Ebitda | 1,621,684,992 |
| Ebitda Margins | 0.35616 |
| Enterprise To Ebitda | 27.516 |
| Enterprise To Revenue | 9.8 |
| Enterprise Value | 44,621,881,344 |
| Eps Current Year | 14.83498 |
| Eps Forward | 16.7397 |
| Eps Trailing Twelve Months | 14.49 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 207 556 4346 |
| Fifty Day Average | 558.9218 |
| Fifty Day Average Change | -3.9318237 |
| Fifty Day Average Change Percent | -0.007034658 |
| Fifty Two Week Change Percent | -14.757997 |
| Fifty Two Week High | 769.98 |
| Fifty Two Week High Change | -214.98999 |
| Fifty Two Week High Change Percent | -0.27921504 |
| Fifty Two Week Low | 518.55 |
| Fifty Two Week Low Change | 36.440002 |
| Fifty Two Week Low Change Percent | 0.070272885 |
| Fifty Two Week Range | 518.55 - 769.98 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 677,511,000,000 |
| Float Shares | 78,499,867 |
| Forward Eps | 16.7397 |
| Forward P E | 33.154118 |
| Free Cashflow | 909,368,384 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 11,000 |
| Fullday Change | 9.90997 |
| Fullday Change Percent | 1.81808 |
| Fullday Price | 554.99 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,785,542,400 |
| Gross Margins | 0.62446 |
| Gross Profits | 2,843,293,952 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.0022 |
| Held Percent Institutions | 0.96847 |
| Implied Shares Outstanding | 78,882,997 |
| Industry | Diagnostics & Research |
| Industry Disp | Diagnostics & Research |
| Industry Key | diagnostics-research |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,434,412,800 |
| Last Split Factor | 2:1 |
| Long Business Summary | IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine. |
| Long Name | IDEXX Laboratories, Inc. |
| Market | us_market |
| Market Cap | 43,779,276,800 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_29729 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | 1,139,655,936 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 42,942,010,709 |
| Number Of Analyst Opinions | 13 |
| Open | 547.81 |
| Operating Cashflow | 1,371,510,016 |
| Operating Margins | 0.3498 |
| Overall Risk | 6 |
| Payout Ratio | 0.0 |
| Peg Ratio | 3.37 |
| Phone | 207 556 0300 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 554.99 |
| Post Market Time | 1,787,959,805 |
| Previous Close | 545.08 |
| Price Eps Current Year | 37.410904 |
| Price Hint | 2 |
| Price To Book | 27.145512 |
| Price To Sales Trailing12 Months | 9.615008 |
| Profit Margins | 0.25030002 |
| Quick Ratio | 0.729 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 2.21429 |
| Region | US |
| Regular Market Change | 9.90997 |
| Regular Market Change Percent | 1.81808 |
| Regular Market Day High | 556.01 |
| Regular Market Day Low | 545.48 |
| Regular Market Day Range | 545.48 - 556.01 |
| Regular Market Open | 547.81 |
| Regular Market Previous Close | 545.08 |
| Regular Market Price | 554.99 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 340,349 |
| Return On Assets | 0.27085 |
| Return On Equity | 0.74211 |
| Revenue Growth | 0.097 |
| Revenue Per Share | 57.169 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 7 |
| Shares Outstanding | 78,882,997 |
| Shares Percent Shares Out | 0.024600001 |
| Shares Short | 1,937,469 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 2,100,008 |
| Short Name | IDEXX Laboratories, Inc. |
| Short Percent Of Float | 0.028099999 |
| Short Ratio | 3.07 |
| Source Interval | 15 |
| State | ME |
| Symbol | IDXX |
| Target High Price | 805.0 |
| Target Low Price | 470.0 |
| Target Mean Price | 698.9231 |
| Target Median Price | 700.0 |
| Total Cash | 196,932,992 |
| Total Cash Per Share | 2.5 |
| Total Debt | 1,096,081,024 |
| Total Revenue | 4,553,223,168 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 14.49 |
| Trailing P E | 38.301586 |
| Trailing Peg Ratio | 3.3383 |
| Triggerable | 1 |
| Two Hundred Day Average | 611.8205 |
| Two Hundred Day Average Change | -56.830505 |
| Two Hundred Day Average Change Percent | -0.09288755 |
| Type Disp | Equity |
| Volume | 340,349 |
| Website | https://www.idexx.com |
| Zip | 4,092 |